Preclinical Development - Biomolecular - Immunogenicity

(M0930-02-08) Development of an Aqueous Formulation of Immulina and the Evaluation of Its Anticancer Effect against B16 Melanoma

(T0930-02-09) Short-Term Administration with Immunosuppressants Suppresses Preclinical Immunogenicity against a Human Monoclonal Antibody in Rats

(M1030-02-09) Assessment of Pre-existing AAV8 Neutralizing Antibody and Total Binding Antibody Assays for Patient Selection

(T1130-02-09) Effect of In Situ Immunization with Vidutolimod in an Oral Leukoplakia Model

(T1130-02-11) A Generic Method Approach to Nonclinical Anti-Drug Antibody Assessment

(W1230-02-09) In Vitro Assessment of Comparative Immunogenicity for Generic Synthetic Peptide Drug Products

(T1330-02-09) Age-Dependent Skeletal Muscle Response to Long-Term Clofazimine Treatment

(M1330-02-09) More than the Sum of Its Parts: In Silico Immunogenicity Risk Assessment for Fusion Proteins and Novel Antibody Modalities

(T1430-02-09) Evaluating the Effect of Nano-Immulina in Mice Peripheral Blood with Emphasis in Immunophenotyping and Neutrophil Phagocytosis